SCHEMBL24145803

SCHEMBL24145803

O=C1C2CN(Cc3ccc(-c4ccccc4)cc3)CCN2C(=O)CN1Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 2/20 0.48
▸ GRM2 Q14416 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ CCR5 P51681 1/20 0.42
▸ DRD2 P14416 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ CHKA P35790 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30337246 0.99 ENPP2 (0.47) ENPP2GRM2CYP2D6CCR5DRD2
SCHEMBL30337582 0.92 SMN1; SMN2 (0.45) CYP2D6THRBTSHRHTR1AL3MBTL1
SCHEMBL30337060 0.92 KMT2A (0.49) ENPP2CHKAHTR1AFAAH
SCHEMBL30337505 0.90 ALDH1A1 (0.46) ENPP2GRM2CCR5ALDH1A1
SCHEMBL30337208 0.89 ENPP2 (0.43) ENPP2GRM2CCR5THRBALDH1A1
SCHEMBL30337392 0.88 ALDH1A1 (0.44) ENPP2CYP2D6CCR5ALDH1A1TSHR
SCHEMBL30337235 0.88 HTR1A (0.43) ENPP2GRM2CYP2D6THRBALDH1A1
SCHEMBL30337191 0.88 HTR1A (0.47) ENPP2DRD2THRBTSHRHTR1A
SCHEMBL24145684 0.86 FAAH (0.39) ENPP2CYP2D6CCR5ALDH1A1TSHR
SCHEMBL30337200 0.86 FAAH (0.39) ENPP2CYP2D6CCR5ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916206-A Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same 治愈医药社株式会社 2023-04-04 — — CN disclosed
WO-2021261969-A1 PREPARATION METHOD FOR NOVEL COMPOUND 홀로스메딕 주식회사 2021-12-30 — — WO disclosed
WO-2021261970-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESISTANT CANCER, COMPRISING SAME 홀로스메딕 주식회사 2021-12-30 — — WO disclosed
Send feedback